Cellular screening identified the first such inhibitors, GANT-61/GANT-58 which block GLI transcription by interfering GLI1- DNA binding and effectively suppress the growth of tumors with elevated GLI1 expression, such as Ewing’s sarcoma (172, 173). This evidence concerns the gene GLI1 and Ewing sarcoma.